Light and challenges: Advances in targeted therapy for glioma
Journal Title: Chinese Journal of Nervous and Mental Diseases - Year 2025, Vol 51, Issue 1
Abstract
Glioma is the most common malignant primary brain tumor in adults, characterized by rapid malignant progression, high recurrence rates, and high mortality. The main treatment methods are surgery followed by radiotherapy and chemotherapy. Temozolomide, as the first-line drug for glioma treatment, is exposed to increasingly severe issues with drug resistance, which significantly impacts the efficacy and prognosis for glioma patients. With advancements in molecular biomarker detection and the emergence of precision medicine, targeted and individualized treatment strategies for glioma patients are evolving rapidly. The discovery of new glioma biomarkers, such as long non-coding RNA HOTAIR (HOX antisense intergenic RNA), polymerase I and transcript release factor (PTRF/Cavin1), and MET, along with the application of new technologies like computer-aided drug design (CADD), has ushered in a new era for the design and development of targeted drugs for glioma. Due to the heterogeneity of glioma, the effectiveness of single-target drugs is limited. In the future, a combination of physical, chemical, and biological interventions will be the breakthrough direction for glioma treatment.
Authors and Affiliations
Dongyuan SU, Chunsheng. KANG
Keywords
Related Articles
- EP ID EP762093
- DOI 10.3969/j.issn.1002-0152.2025.01.001
- Views 36
- Downloads 0
Advances in the diagnosis and treatment of chronic subdural hematoma
Chronic subdural hematoma is one of the common central nervous system diseases in middle-aged and elderly people, and the incidence is increasing year by year. Drill and drain surgery is recognized as one of the effectiv...
An intervention study of right unilateral modified electroconvulsive therapy for major depressive disorder
ObjectiveTo explore the effect and safety of right unilateral modified electroconvulsive therapy (RUL-MECT) for major depressive disorder patients (MDD).MethodsA randomized controlled trial was conducted on 70 patients w...
Construction of diagnostic model of depression in insomnia patients based on polysomnography data
[Objective] To establish a diagnostic model for depression in insomnia patients by mining polysomnography (PSG) data of insomnia patients with machine learning algorithms, and to provide a scientific basis for the diagno...
Study on the mechanism of losartan reducing the risk of comorbid depression in epileptic rats
[Objective] To investigate the effectiveness and mechanisms of losartan in improving comorbid depression in epileptic rats. [Methods] Male rats were randomly divided into three groups: The losartan-pilocarpine group (PL-...
Establishment of stable Schwann cell lines with genetic intervention of MST2 and its appliance in the detection of mitochondrial membrane potential
[Objective] To construct rat Schwann cell RSC96 cell lines that stably knock down or overexpress mammalian ste20-like kinase 2 (MST2), and preliminarily explore its regulatory effect on mitochondrial membrane potential....